<DOC>
	<DOCNO>NCT00384527</DOCNO>
	<brief_summary>The primary objective study demonstrate non-inferiority nitazoxanide compare vancomycin resolve symptom Clostridium difficile-associated disease ( CDAD ) .</brief_summary>
	<brief_title>Study Nitazoxanide Treatment Clostridium Difficile-associated Disease</brief_title>
	<detailed_description />
	<mesh_term>Clostridium Infections</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Nitazoxanide</mesh_term>
	<criteria>Age ≥ 18 year . Patients new onset disease evidence diarrhea ( ≥ 3 unformed stool within 24 hour ) , one follow symptom CDAD : abdominal pain cramp peripheral leukocytosis fever C. difficile toxin A B detect stool specimen obtain within 3 day enrollment enzyme immunoassay . Patients willing avoid follow medication study : oral intravenous metronidazole oral vancomycin antiperistaltic drug opiate ( patient opiates may include study take opiate prior enrollment dose increase study ) Saccharomyces cerevisiae ( baker 's yeast ) Lactobacillus GG cholestyramine colestipol Patients known cause diarrhea colitis ( e.g. , Shigella , Salmonella , Cryptosporidium parvum , Giardia lamblia , Entamoeba histolytica , inflammatory bowel disease , irritable bowel syndrome , advance AIDS chemotherapy malignancy ) . Patients commonly 3 stool per day and/or severe abdominal pain absence CDAD . Patients severe lactose intolerance . Patients 1 recurrence CDAD 6 month prior enrollment . Patients unable take oral medication . Use within 1 week enrollment drug therapy antiC . difficile activity oral intravenous metronidazole oral vancomycin . [ Patients take 3 dos metronidazole vancomycin include study ] . Females child bear age either pregnant , breastfeed use birth control sexually active . Patients either clinically unstable ( e.g. , fulminant disease patient sign toxic megacolon , imminent perforation , colectomy death ) unlikely live throughout 31day duration study due underlie illness . History hypersensitivity nitazoxanide vancomycin active ingredient formulation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Clostridium difficile</keyword>
</DOC>